What do the three letters in DoTS stand for?

DoTS stands for Dose, Time-course, and Susceptibility. Each adverse drug reaction is described on all three axes at once rather than placed in a single category, which captures more information than a one-letter label.

How is DoTS different from the Type A / Type B classification?

Type A / Type B assigns a reaction to one of two categories based mainly on predictability and dose. DoTS instead profiles the reaction independently along dose-relation, time-course, and individual susceptibility, distinguishing reactions that the binary scheme would lump together.

Dose-Time-Course-Susceptibility (DoTS) Framework

The Dose-Time-Course-Susceptibility (DoTS) framework is a multi-axis system for classifying adverse drug reactions, proposed by Aronson and Ferner to overcome the ambiguities of the simple Type A / Type B dichotomy. Instead of forcing a reaction into one category, DoTS describes it along three orthogonal dimensions — the relation to dose, the temporal pattern, and the individual susceptibility involved.

Definition

DoTS is a three-axis classification of adverse drug reactions that characterizes each reaction by its relation to Dose (toxic effects, collateral effects at therapeutic doses, or hypersusceptibility effects below normal doses), its Time-course (time-independent versus time-dependent patterns such as immediate, early, intermediate, late, or delayed), and the patient's Susceptibility (factors such as age, sex, physiology, exogenous influences, and disease that raise or lower individual risk).

Scope

This entry sets out the three DoTS axes and their subcategories, explains how a single reaction is characterized on all three at once, and contrasts the approach with the binary Rawlins-Thompson scheme. It is a conceptual classification topic; it does not provide management protocols, and detailed mechanisms of immune or idiosyncratic reactions are delegated to the sibling topic on idiosyncratic and hypersensitivity reactions.

Core questions

What are the three axes of the DoTS framework, and what does each describe?
How does DoTS classify a reaction's relation to dose?
What time-course patterns does DoTS distinguish?
Why was a multi-axis framework preferred over the Type A / Type B dichotomy?

Key concepts

Dose axis: toxic, collateral, and hypersusceptibility effects
Time-course axis: time-independent versus time-dependent reactions
Immediate, early, intermediate, late, and delayed reactions
Susceptibility axis: host risk-modifying factors
Orthogonal multi-dimensional classification
Mechanism- and prevention-oriented description

Mechanisms

DoTS separates features that the Type A / Type B scheme conflates. On the dose axis, a reaction may be a toxic effect occurring above the therapeutic range, a collateral effect occurring within the normal therapeutic range, or a hypersusceptibility effect occurring even below normal doses in susceptible individuals. On the time-course axis, reactions are either time-independent (occurring whenever concentration is high enough) or time-dependent, with subcategories spanning rapid (infusion-related), first-dose, early, intermediate, late (including withdrawal), and delayed effects. On the susceptibility axis, individual risk is modulated by genetic variation, age, sex, altered physiology, concurrent disease, and exogenous factors such as interacting drugs. Because the axes are orthogonal, two reactions that would both be labelled Type B can be distinguished in detail, which supports clearer reasoning about prevention and mechanism.

Clinical relevance

By describing dose-relation, timing, and susceptibility separately, DoTS gives clinicians and pharmacovigilance analysts a more granular vocabulary for thinking about how a reaction might be anticipated or avoided in general terms. The framework is an educational and analytic tool; it does not prescribe dosing, monitoring, or treatment for any individual patient.

History

Aronson and Ferner introduced DoTS in the BMJ in 2003 as a response to the recognized shortcomings of the Rawlins-Thompson dichotomy and its letter-based extensions, which they argued mixed together logically independent properties. By making dose, time, and susceptibility explicit and orthogonal axes, DoTS aimed to produce classifications that map more directly onto mechanism, prediction, and prevention.

Debates

Does added granularity outweigh added complexity?: DoTS captures information the binary scheme loses, but its multi-axis descriptions are more elaborate and less mnemonic than Type A / Type B, so the simpler dichotomy persists in introductory teaching while DoTS is favoured for detailed mechanistic and pharmacovigilance reasoning.

Key figures

Jeffrey K. Aronson
Robin E. Ferner
I. Ralph Edwards

Seminal works

aronson-ferner-2003

Frequently asked questions

What do the three letters in DoTS stand for?: DoTS stands for Dose, Time-course, and Susceptibility. Each adverse drug reaction is described on all three axes at once rather than placed in a single category, which captures more information than a one-letter label.
How is DoTS different from the Type A / Type B classification?: Type A / Type B assigns a reaction to one of two categories based mainly on predictability and dose. DoTS instead profiles the reaction independently along dose-relation, time-course, and individual susceptibility, distinguishing reactions that the binary scheme would lump together.